Active Ingredient: Choriogonadotropin alpha
Choriogonadotropin alpha is indicated in the treatment of anovulatory or oligo-ovulatory adult women: Choriogonadotropin alpha is administered to trigger ovulation and luteinisation in anovulatory or oligo-ovulatory women after stimulation of follicular growth.
For this indication, competent medicine agencies globally authorize below treatments:
Subcutaneous
250 - 250 ug
From 250 To 250 ug once every day
The maximum dose is 250 micrograms. The following dose regimen should be used in anovulatory or oligo-ovulatory women: One pre-filled syringe of choriogonadotropin alpha (250 micrograms) is administered 24 to 48 hours after optimal stimulation of follicular growth is achieved. The patient is recommended to have coitus on the day of, and the day after, choriogonadotropin alpha injection.
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.
